| Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update NS Key, AA Khorana, NM Kuderer, K Bohlke, AYY Lee, JI Arcelus, ... Journal of Clinical Oncology 38 (5), 496-520, 2020 | 1329 | 2020 |
| American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer GH Lyman, AA Khorana, A Falanga, D Clarke-Pearson, C Flowers, ... Journal of clinical oncology 25 (34), 5490-5505, 2007 | 1314 | 2007 |
| Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial DJ Kuter, JB Bussel, RM Lyons, V Pullarkat, TB Gernsheimer, FM Senecal, ... The Lancet 371 (9610), 395-403, 2008 | 1085 | 2008 |
| The ITP syndrome: pathogenic and clinical diversity DB Cines, JB Bussel, HA Liebman, ET Luning Prak Blood, The Journal of the American Society of Hematology 113 (26), 6511-6521, 2009 | 993 | 2009 |
| Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update GH Lyman, AA Khorana, NM Kuderer, AY Lee, JI Arcelus, EP Balaban, ... Journal of Clinical Oncology 31 (17), 2189-2204, 2013 | 986 | 2013 |
| Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014 GH Lyman, K Bohlke, AA Khorana, NM Kuderer, AY Lee, JI Arcelus, ... Journal of Clinical Oncology 33 (6), 654, 2015 | 913 | 2015 |
| DES-GAMMA-CARBOXY (ABNORMAL) PROTHROMBIN-A NEW SERUM MARKER OF PRIMARY HEPATOCELLULAR-CARCINOMA HA Liebman, BC Furie, RA Blanchard, MJ Tong, KJ Lo, SD Lee, B Furie CLINICAL RESEARCH 31 (2), A476-A476, 1983 | 808 | 1983 |
| The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study CN Bernstein, JF Blanchard, DS Houston, A Wajda Thrombosis and haemostasis 85 (03), 430-434, 2001 | 736 | 2001 |
| Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer AA Khorana, GA Soff, AK Kakkar, S Vadhan-Raj, H Riess, T Wun, ... New England Journal of Medicine 380 (8), 720-728, 2019 | 661 | 2019 |
| Tumor-derived tissue factorbearing microparticles are associated with venous thromboembolic events in malignancy JI Zwicker, HA Liebman, D Neuberg, R Lacroix, KA Bauer, BC Furie, ... Clinical Cancer Research 15 (22), 6830-6840, 2009 | 633 | 2009 |
| 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ... The Lancet Oncology 20 (10), e566-e581, 2019 | 448 | 2019 |
| Treatment of adult T-cell leukemia–lymphoma with a combination of interferon alfa and zidovudine PS Gill, W Harrington Jr, MH Kaplan, RC Ribeiro, JM Bennett, ... New England Journal of Medicine 332 (26), 1744-1748, 1995 | 437 | 1995 |
| Pathobiology of secondary immune thrombocytopenia DB Cines, H Liebman, R Stasi Seminars in hematology 46, S2-S14, 2009 | 335 | 2009 |
| Once-daily administration of 2′, 3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: results of a phase I trial TP Cooley, LM Kunches, CA Saunders, JK Ritter, CJ Perkins, C McLaren, ... New England Journal of Medicine 322 (19), 1340-1345, 1990 | 326 | 1990 |
| Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. PS Gill, BM Espina, F Muggia, S Cabriales, A Tulpule, JA Esplin, ... Journal of clinical Oncology 13 (4), 996-1003, 1995 | 325 | 1995 |
| Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment DE Sutherland, IC Weitz, HA Liebman American journal of hematology 72 (1), 43-52, 2003 | 295 | 2003 |
| Increased microparticle tissue factor activity in cancer patients with venous thromboembolism DA Manly, J Wang, SL Glover, R Kasthuri, HA Liebman, NS Key, ... Thrombosis research 125 (6), 511-512, 2010 | 261 | 2010 |
| Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group F Rodeghiero, M Michel, T Gernsheimer, M Ruggeri, V Blanchette, ... Blood, The Journal of the American Society of Hematology 121 (14), 2596-2606, 2013 | 259 | 2013 |
| A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer MN Levine, C Gu, HA Liebman, CP Escalante, S Solymoss, D Deitchman, ... Journal of Thrombosis and Haemostasis 10 (5), 807-814, 2012 | 213 | 2012 |
| Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis LAJ Kluijtmans, M Den Heijer, PH Reitsma, SG Heil, HJ Blom, ... Thrombosis and haemostasis 79 (02), 254-258, 1998 | 206 | 1998 |
